medigraphic.com
ISSN 1560-4381 (Print)

2020, Number 3

<< Back Next >>

Correo Científico Médico 2020; 24 (3)

Clinical epidemiological characteristics and some reflections about COVID 19 in Holguín, Cuba, 2020

Garrido TEJ, Manso LAM, Salermo RMÁ, Ramírez RG, Pérez RVR

Language: Spanish
References: 28
Page: 839-855
PDF size: 355.05 Kb.


ABSTRACT

Introduction: SARS CoV 2 is the causal agent of COVID 19, which has already become a pandemic that plagues the world with significant mortality rates, whose clinical epidemiological characteristics are still surroun ded by various scientific gaps.
Objective: To characterize clinically and epidemiologically COVID 19 cases in Holguín.
Method: Observational descriptive study of COVID 19 pandemic in the province. The 92 cases confirmed by PCR were characterized, taking i nto account the epidemiological variables of age, sex, place of origin, presence of symptoms at diagnosis, opportunity at admission and main symptoms; in addition, the incidence and fatality rates were determined.
Results: Male sex predominated; the mo st affected age group was the one between 50 and 59 years; the most affected municipalities were Holguín, Gibara and Banes; the main symptoms at the beginning of the disease were cough, fever, runny nose and odynophagia, but more than half of the cases wer e asymptomatic at the time of diagnosis and they did not present secondary cases; less than a third of the cases were admitted in the first days after the symptoms started, which influenced their subsequent evolution and convalescence.
Conclusions: COVID 1 9 is a highly contagious respiratory disease that must be adequately cared for in order to reduce its lethality and for which the epidemiological control of each suspected case takes on great importance.


REFERENCES

  1. SEOR. Información Científica Técnica Enfermedad por coronavirus, COVID 19 E spaña: Sociedad Española de Oncología Radioterápica 2020. Disponible en: https://seor.es/covid19/informacion cientifica tecnica enfe rmedad por coronavirus covid 19/

  2. WHO. Novel Coronavirus (2019 nCoV) situation reports 3. Geneva:WHO;23/01/2020[citado 23 /02/2020]. Disponible en: http s://apps.who.int/iris/bitstream/handle/10665/330762/nCoVsitrep23Jan2020 eng.pdf

  3. Paules CI, Marston HD, Fauci AS. Coronavirus Infections More Than Just the Common Cold. JAMA. 2020 [citado 0 6 /02/ 2020];323(8):707 708 Disponible en: https://jamanetwork.com/journals/jama/article abstract/2759815

  4. World Health organization. Report of the WHO China Joint Mission on Coronavirus Disease 2019 (COVID 19). 2020. Disponible en: https://www.who.int/publications/i/item/report of the who china joint mission on coronavirus disease 2019 --(covid 19)

  5. H olshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H.et al. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med 2020 [citado 26/02/ 2020];382:929 936.Disponible en: https://www.nejm.org/doi/full/10.1056/NEJMoa2001191

  6. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W. et al. Clinical characteristics and intrauterine vertical transmission potential of COVID 19 infection in nine pregnant women: a retrospective review of medical records. The Lancet . 2020 [citado 13 /02/ 2020];395(10226):809 815.Disponible en: https://pubmed.ncbi.nlm.nih.gov/321 51335/

  7. Saif LJ. Animal coronavirus: lessons for SARS. National Academies Press (US); 2004 [citado 0 6 /02/ 2020]. Disponible en: https://www.ncbi.nlm. nih.gov/books/NBK92442/

  8. Bélgica: Institué auprès de l’Agence Fédérale pourla Sécurité de la Chaîne Alimentaire. Risque zoonotique du SARS CoV2 (Covid 19) associé aux animaux de compagnie : infection de l’animal vers l’homme et de l’homme vers l’animal, 2020. Disponible en: http://www.afsca.be/comitescientifique/avis/2020/_documents/Conseilurgentprovisoire0 4 2020_SciCom2020 07_Covid 19petitsanimauxdomestiques_27 03 20_001.pdf

  9. Pengfei C, Jinliang W, Xianfeng Z, Yuntao G, Hualan C, Zhigao B.Susceptibility of ferrets, cats, dogs, and different domestic animals to SARS coronavirus 2.BioRxiv. 2020[citado 0 4 /04/ 2020] Disponible en: https://www.biorxiv.org/content/10.1101/2020.03.30.015347v1

  10. Hung LS. The SARS epidemic in Hong Kong: what lessons have we learned? J R Soc Med .2003 [citado 26 / 2020];96(8):374 8. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC539564/

  11. OPS. Water, sanitation, hygiene and waste management for COVID 19.Washington:O PS 19/03/ 2020 [citado 19/03/ 2020]. Disponible en: https://covid19 evidence.paho.org/handle/20.500.12663/843

  12. Doremalen N , Bushmaker T, Morris D, Holbrook M, Gamble A , Williamson B et al . Aerosol and surface stability of HCoV 19 (SARS CoV 2) compared to SARS CoV 1. MedRx . 2020 [citado 16 /05/ Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC72170 62/

  13. Perera M, Hui K, Yen H Chan, Peiris M, Poon L. Stability of SARS CoV 2 in different environmental conditions. MedRxiv. 2020 [citado 1 4 /04/2020]. Disponible en: htt ps://www.medrxiv.org/content/10.1101/2020.03.15.20036673v2

  14. Liu Y, Ning Z , Chen Y, Guo M, Liu Y, Gali et al . Aerodynamic Characteristics and RNA Concentration of SARS CoV 2 Aerosol in Wuhan Hospitals during COVID 19 Outbreak. BioRxiv. 2020 [citad o 25 /03/ 2020] Disponible en: https://www.biorxiv.org/content/10.1101/2020.03.08.982637v1.abstract

  15. Guan W, N i Z, Hu Y, Liang W, Ou C, He J, et al . Clinical Character istics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 [citado 1 6 /03/ 2020];382:1708 1720 Disponible en: https://www.nejm.org/doi/full/10.1056/NEJMoa2002032

  16. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y. et al . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus Infec ted Pneumonia. N Engl J Med 2020 [citado 1 6 /02/ 2020]; 328(13):1199 1207. Disponible en: https://www.nejm.org/doi/pdf/10.1056/NEJMoa2001316?articleTools=true

  17. Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019 nCoV outbreak originating in Wuhan, China : a modelling study. Lancet. 2020 [citado 2 6 /02/ 2020]; 395 10225 ): 689 697. Disponible en: https://www.sciencedirect.com/science/article/pii/S0140673620302609

  18. Riou J, Althaus CL. Pattern of early human to human transmission of Wuhan 2019 novel coronavirus (2019 nCoV), December 2019 to January 2020 Euro Surveill .2020. [citado 0 6 /02/2020 ];25(4): Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001239/

  19. Burke R,Burke M; Midgley CM, Dratch A, Fenstersheib, M Haupt T. Active Monitoring of Persons Exposed to Patients with Confirmed COVID 19 United States, January February 2020. Centers for disease control and prevention . 2020 [citado 04 /03/2020];69(9);245 246 Disponible en: https://www.cdc.gov/mmwr/volume s/69/wr/mm6909e1.htm?fbclid=IwAR1Rj1iW D_V7PEIIRCK15bSKMj19rKmHRWxZeihhgiyW_5TVoZwsjnFXnc

  20. Rothe C, Schunk M, Sothmann P, Bre tzel G, Froeschl G, Wallrauch C, et al . Transmission of 2019 nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med . 2020 [citado 0 4 /02/ 2020];382:970 971 Disponible en: https://www.nejm.org/doi/full/10.1056/NEJMc2001468

  21. Pierre Alvarez R, Harris P. COVID 19 en América Latina: Retos y oportuni dades. Rev. chil. pediatr. 2 020[citado 04 /02/ 2020]; 91(2) Disponible en: https://scielo.conicyt.cl/scielo.php?pid=S0370 41062020005000602&script=sci_artte xt

  22. Narayanan K. Study claiming new coronavirus can be transmitted by people without symptoms was flawed. Science. [citado 0 3 /02/ 2020 ]]. Disponible en: https://www.sciencemag.org/news/2020/02/paper non symptomatic patient transmitting coronavirus wrong

  23. Bai Y, Yao L , Wei T, Tian F, Jin D Y, Chen , et al . Presumed Asymptomatic Carrier Transmission of COVID 19. JAMA. 2020 [ citado 2 6 / 03/ 2020]; 323(14):1406 1407.Disponible en: https://jamanetwork.com/journals/jama/article abstract/2762028

  24. Tong Z D, Tang A, Li K F, Li P, Wang H L, Yi J P. et al. Potenti al Presymptomatic Transmission of SARS CoV 2, Zhejiang Province, China. Emerg Infect Dis. 2020 [citado 17 /03/ 2020];26(5):1052 1054. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/arti cles/PMC7181913/

  25. Xing Yuanyuan Mo Pingzheng , Xiao Yu , Zhao Oiu , Zhang Yongxi , Wang Fan . Post discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID 19), China, January to February 2020. Euro Surveill ance 2020 [citado 12/04/2020];25(10): 2000191. https://www.eurosurveillance.org/content/10.2807/1560 79 17.ES.2020.25.10.2000191

  26. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et a l . Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China . JAMA Neurol [citado 04/04/ 2020]2020];77(6):1 9 . Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149362/

  27. Zheng Y Y, Ma Y T, Zhang J Y, Xie X. COVID 19 and the cardiovascular system. Nat Rev Cardiol . 2020 [citado 16 /03/ 2020]; 17 259 260. Disponible en : https://www.nature.com/articles/s41569 020 0360 5?fbclid=IwAR3TjvxiEtYQqNkpsPuEuuef94Gp2m4a89YFxubY2pw2FtOxsSpxGZ18TmI

  28. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H. et al. Clinical course and outcomes of critically ill patients with SARS CoV 2 pneumonia in Wuhan, China: a single centered, retrospective, observational study. Lancet Respir Med. 2020 [citado 1 6 /03/ 2020];8( 5):475 481. Disponible en: https://www.sciencedirect.com/science/article/pii/S2213260020300795




2020     |     www.medigraphic.com